Owner Portola Pharmaceuticals, Inc.

Inventors Mehrotra, Mukund; Pandey, Anjali; Song, Yonghong; Jia, Zhaozhong J.; Xu, Qing; Bauer, Shawn M.

Agent Davies Collison Cave

Pub. Number AU-A-2009238590

PCT Pub. Number WO2009/131687

Priority 61/047,077 22.04.08 US

Filing date 22 April 2009

Wipo publication date 29 October 2009

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/52 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems